Skip to main content
Top
Published in: Inflammation 2/2016

01-04-2016 | ORIGINAL ARTICLE

Licochalcone A Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting NF-κB Activation

Authors: Jun Hu, Jun Liu

Published in: Inflammation | Issue 2/2016

Login to get access

Abstract

Licochalcone A (Lico A), a flavonoid found in licorice root (Glycyrrhiza glabra), has been reported to have anti-inflammatory activity. However, the protective effects of Lico A on lipopolysaccharide (LPS)-induced acute kidney injury (AKI) remains unclear. In this study, using a mouse model of LPS-induced AKI, we investigated the protective effects and mechanism of Lico A on LPS-induced AKI in mice. LPS-induced kidney injury was assessed by detecting kidney histological study, blood urea nitrogen (BUN), and creatinine levels. The production of inflammatory cytokines TNF-α, IL-6, and IL-1β in serum and kidney tissues was detected by ELISA. The activation of NF-κB was measured by western blot analysis. Our results showed that Lico A dose-dependently attenuated LPS-induced kidney histopathologic changes, serum BUN, and creatinine levels. Lico A also suppressed LPS-induced TNF-α, IL-6, and IL-1β production both in serum and kidney tissues. Furthermore, our results showed that Lico A significantly inhibited LPS-induced NF-κB activation. In conclusion, our results suggest that Lico A has protective effects against LPS-induced AKI and Lico A exhibits its anti-inflammatory effects through inhibiting LPS-induced NF-κB activation.
Literature
1.
go back to reference Marshall, J.C., J.-L. Vincent, G. Guyatt, D.C. Angus, E. Abraham, G. Bernard, C. Bombardier, T. Calandra, H.S. Jørgensen, and R. Sylvester. 2005. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis forum. Critical Care Medicine 33: 1708–1716.CrossRefPubMed Marshall, J.C., J.-L. Vincent, G. Guyatt, D.C. Angus, E. Abraham, G. Bernard, C. Bombardier, T. Calandra, H.S. Jørgensen, and R. Sylvester. 2005. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis forum. Critical Care Medicine 33: 1708–1716.CrossRefPubMed
3.
go back to reference Zarjou, A., and A. Agarwal. 2011. Sepsis and acute kidney injury. Journal of the American Society of Nephrology 22: 999–1006.CrossRefPubMed Zarjou, A., and A. Agarwal. 2011. Sepsis and acute kidney injury. Journal of the American Society of Nephrology 22: 999–1006.CrossRefPubMed
4.
go back to reference Cunningham, P.N., Y. Wang, R. Guo, G. He, and R.J. Quigg. 2004. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. The Journal of Immunology 172: 2629–2635.CrossRefPubMed Cunningham, P.N., Y. Wang, R. Guo, G. He, and R.J. Quigg. 2004. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. The Journal of Immunology 172: 2629–2635.CrossRefPubMed
5.
go back to reference Gupta, A., G.J. Rhodes, D.T. Berg, B. Gerlitz, B.A. Molitoris, and B.W. Grinnell. 2007. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. American Journal of Physiology—Renal Physiology 293: F245–F254.CrossRefPubMed Gupta, A., G.J. Rhodes, D.T. Berg, B. Gerlitz, B.A. Molitoris, and B.W. Grinnell. 2007. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. American Journal of Physiology—Renal Physiology 293: F245–F254.CrossRefPubMed
6.
go back to reference Cho, S.-Y., S.-J. Park, M.-J. Kwon, T.-S. Jeong, S.-H. Bok, W.-Y. Choi, W.-I. Jeong, S.-Y. Ryu, S.-H. Do, and C.-S. Lee. 2003. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-κB pathway in lipopolysaccharide-stimulated macrophage. Molecular and Cellular Biochemistry 243: 153–160.CrossRefPubMed Cho, S.-Y., S.-J. Park, M.-J. Kwon, T.-S. Jeong, S.-H. Bok, W.-Y. Choi, W.-I. Jeong, S.-Y. Ryu, S.-H. Do, and C.-S. Lee. 2003. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-κB pathway in lipopolysaccharide-stimulated macrophage. Molecular and Cellular Biochemistry 243: 153–160.CrossRefPubMed
8.
go back to reference Liu, C.-M., Y.-Z. Sun, J.-M. Sun, J.-Q. Ma, and C. Cheng. 2012. Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-κB pathway. Biochimica et Biophysica Acta (BBA)—General Subjects 1820: 1693–1703.CrossRef Liu, C.-M., Y.-Z. Sun, J.-M. Sun, J.-Q. Ma, and C. Cheng. 2012. Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-κB pathway. Biochimica et Biophysica Acta (BBA)—General Subjects 1820: 1693–1703.CrossRef
9.
go back to reference Shen, H., G. Zeng, G. Tang, X. Cai, L. Bi, C. Huang, and Y. Yang. 2014. Antimetastatic effects of licochalcone A on oral cancer via regulating metastasis-associated proteases. Tumour Biology 35: 7467–7474.CrossRefPubMed Shen, H., G. Zeng, G. Tang, X. Cai, L. Bi, C. Huang, and Y. Yang. 2014. Antimetastatic effects of licochalcone A on oral cancer via regulating metastasis-associated proteases. Tumour Biology 35: 7467–7474.CrossRefPubMed
10.
go back to reference Fontes, L.B., Dias D. Dos Santos, L.S. de Carvalho, H.L. Mesquita, Reis L. da Silva, A.T. Dias, A.A. Da Silva Filho, and J.O. do Amaral Correa. 2014. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis. Journal of Pharmacy and Pharmacology 66: 886–894.PubMed Fontes, L.B., Dias D. Dos Santos, L.S. de Carvalho, H.L. Mesquita, Reis L. da Silva, A.T. Dias, A.A. Da Silva Filho, and J.O. do Amaral Correa. 2014. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis. Journal of Pharmacy and Pharmacology 66: 886–894.PubMed
11.
go back to reference Kwon, H.S., J.H. Park, D.H. Kim, Y.H. Kim, J.H. Park, H.K. Shin, and J.K. Kim. 2008. Licochalcone A isolated from licorice suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice. Journal of Molecular Medicine 86: 1287–1295.CrossRefPubMed Kwon, H.S., J.H. Park, D.H. Kim, Y.H. Kim, J.H. Park, H.K. Shin, and J.K. Kim. 2008. Licochalcone A isolated from licorice suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice. Journal of Molecular Medicine 86: 1287–1295.CrossRefPubMed
12.
go back to reference Chu, X., X. Ci, M. Wei, X. Yang, Q. Cao, M. Guan, H. Li, Y. Deng, H. Feng, and X. Deng. 2012. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. Journal of Agricultural and Food Chemistry 60: 3947–3954.CrossRefPubMed Chu, X., X. Ci, M. Wei, X. Yang, Q. Cao, M. Guan, H. Li, Y. Deng, H. Feng, and X. Deng. 2012. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. Journal of Agricultural and Food Chemistry 60: 3947–3954.CrossRefPubMed
13.
go back to reference Simmons, E.M., J. Himmelfarb, M.T. Sezer, G.M. Chertow, R.L. Mehta, E.P. Paganini, S. Soroko, S. Freedman, K. Becker, and D. Spratt. 2004. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney International 65: 1357–1365.CrossRefPubMed Simmons, E.M., J. Himmelfarb, M.T. Sezer, G.M. Chertow, R.L. Mehta, E.P. Paganini, S. Soroko, S. Freedman, K. Becker, and D. Spratt. 2004. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney International 65: 1357–1365.CrossRefPubMed
14.
go back to reference Murray, P., and J. Hall. 2000. Renal replacement therapy for acute renal failure. American Journal of Respiratory and Critical Care Medicine 162: 777–781.CrossRefPubMed Murray, P., and J. Hall. 2000. Renal replacement therapy for acute renal failure. American Journal of Respiratory and Critical Care Medicine 162: 777–781.CrossRefPubMed
15.
go back to reference Bostom, A.G., F. Kronenberg, and E. Ritz. 2002. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. Journal of the American Society of Nephrology 13: 2140–2144.CrossRefPubMed Bostom, A.G., F. Kronenberg, and E. Ritz. 2002. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. Journal of the American Society of Nephrology 13: 2140–2144.CrossRefPubMed
16.
go back to reference Clarkson, P.M., A.K. Kearns, P. Rouzier, R. Rubin, and P.D. Thompson. 2006. Serum creatine kinase levels and renal function measures in exertional muscle damage. Medicine and Science in Sports and Exercise 38: 623.CrossRefPubMed Clarkson, P.M., A.K. Kearns, P. Rouzier, R. Rubin, and P.D. Thompson. 2006. Serum creatine kinase levels and renal function measures in exertional muscle damage. Medicine and Science in Sports and Exercise 38: 623.CrossRefPubMed
17.
go back to reference House, A.A., and C. Ronco. 2008. Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury. Blood Purification 26: 30–35.CrossRefPubMed House, A.A., and C. Ronco. 2008. Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury. Blood Purification 26: 30–35.CrossRefPubMed
18.
go back to reference Lee, D.H., M.H. Park, C.J. Hwang, J.Y. Hwang, H.S. Yoon, D.Y. Yoon, and J.T. Hong. 2015. CCR5 deficiency increased susceptibility to lipopolysaccharide-induced acute renal injury. Archives of Toxicology. doi:10.1007/s00204-015-1530-9. Lee, D.H., M.H. Park, C.J. Hwang, J.Y. Hwang, H.S. Yoon, D.Y. Yoon, and J.T. Hong. 2015. CCR5 deficiency increased susceptibility to lipopolysaccharide-induced acute renal injury. Archives of Toxicology. doi:10.​1007/​s00204-015-1530-9.
19.
go back to reference Xu, C., A. Chang, B.K. Hack, M.T. Eadon, S.L. Alper, and P.N. Cunningham. 2014. TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Kidney International 85: 72–81.CrossRefPubMedPubMedCentral Xu, C., A. Chang, B.K. Hack, M.T. Eadon, S.L. Alper, and P.N. Cunningham. 2014. TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Kidney International 85: 72–81.CrossRefPubMedPubMedCentral
20.
go back to reference Miyazaki, H., J. Morishita, M. Ueki, K. Nishina, S. Shiozawa, and N. Maekawa. 2012. The effects of a selective inhibitor of c-Fos/activator protein-1 on endotoxin-induced acute kidney injury in mice. BMC Nephrology 13. Miyazaki, H., J. Morishita, M. Ueki, K. Nishina, S. Shiozawa, and N. Maekawa. 2012. The effects of a selective inhibitor of c-Fos/activator protein-1 on endotoxin-induced acute kidney injury in mice. BMC Nephrology 13.
21.
go back to reference Xu, D., M. Chen, X. Ren, X. Ren, and Y. Wu. 2014. Leonurine ameliorates LPS-induced acute kidney injury via suppressing ROS-mediated NF-kappaB signaling pathway. Fitoterapia 97: 148–155.CrossRefPubMed Xu, D., M. Chen, X. Ren, X. Ren, and Y. Wu. 2014. Leonurine ameliorates LPS-induced acute kidney injury via suppressing ROS-mediated NF-kappaB signaling pathway. Fitoterapia 97: 148–155.CrossRefPubMed
22.
go back to reference Takahashi, K., H. Mizukami, K. Kamata, W. Inaba, N. Kato, C. Hibi, and S. Yagihashi. 2012. Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat. Plos One 7. Takahashi, K., H. Mizukami, K. Kamata, W. Inaba, N. Kato, C. Hibi, and S. Yagihashi. 2012. Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat. Plos One 7.
23.
go back to reference Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NF-κB transcription factors in the immune system. Annual Review of Immunology 27: 693–733.CrossRefPubMed Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NF-κB transcription factors in the immune system. Annual Review of Immunology 27: 693–733.CrossRefPubMed
24.
go back to reference Bonizzi, G., and M. Karin. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends in Immunology 25: 280–288.CrossRefPubMed Bonizzi, G., and M. Karin. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends in Immunology 25: 280–288.CrossRefPubMed
25.
go back to reference Sanz, A.B., M.D. Sanchez-Niño, A.M. Ramos, J.A. Moreno, B. Santamaria, M. Ruiz-Ortega, J. Egido, and A. Ortiz. 2010. NF-κB in renal inflammation. Journal of the American Society of Nephrology 21: 1254–1262.CrossRefPubMed Sanz, A.B., M.D. Sanchez-Niño, A.M. Ramos, J.A. Moreno, B. Santamaria, M. Ruiz-Ortega, J. Egido, and A. Ortiz. 2010. NF-κB in renal inflammation. Journal of the American Society of Nephrology 21: 1254–1262.CrossRefPubMed
26.
go back to reference Baldwin Jr., A.S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annual Review of Immunology 14: 649–681.CrossRefPubMed Baldwin Jr., A.S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annual Review of Immunology 14: 649–681.CrossRefPubMed
27.
go back to reference Fitzgerald, K.A., D.C. Rowe, B.J. Barnes, D.R. Caffrey, A. Visintin, E. Latz, B. Monks, P.M. Pitha, and D.T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. The Journal of Experimental Medicine 198: 1043–1055.CrossRefPubMedPubMedCentral Fitzgerald, K.A., D.C. Rowe, B.J. Barnes, D.R. Caffrey, A. Visintin, E. Latz, B. Monks, P.M. Pitha, and D.T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. The Journal of Experimental Medicine 198: 1043–1055.CrossRefPubMedPubMedCentral
Metadata
Title
Licochalcone A Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting NF-κB Activation
Authors
Jun Hu
Jun Liu
Publication date
01-04-2016
Publisher
Springer US
Published in
Inflammation / Issue 2/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-015-0281-3

Other articles of this Issue 2/2016

Inflammation 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.